This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Fouad Zakharia: Innovator in Genomic Technologies
Introduction
Fouad Zakharia is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of genomics, particularly in the area of haplotype determination. His innovative work has implications for understanding genetic variations within populations.
Latest Patents
Fouad Zakharia holds a patent titled "Techniques for determining haplotype by population genotype and sequence data." This patent describes a novel phasing algorithm that utilizes sequencing read information from next-generation sequencing technologies. The algorithm enhances local haplotype reconstruction from genotypes by determining correlated occurrences of single nucleotide polymorphisms (SNPs) in genes across a population. The method involves analyzing a plurality of sequences of nucleotide bases from individuals within the population, based on ultra-high throughput sequencing. The inclusion of paired-end read data is particularly beneficial for phasing rare variants, including singletons.
Career Highlights
Fouad Zakharia is affiliated with Leland Stanford Junior University, where he continues to advance research in genomic technologies. His work has garnered attention for its innovative approach to genetic analysis and its potential applications in personalized medicine.
Collaborations
Fouad collaborates with Carlos Daniel Bustamante, a fellow researcher in the field. Their partnership enhances the research output and fosters innovation in genomic studies.
Conclusion
Fouad Zakharia's contributions to genomic technologies through his patent and research at Leland Stanford Junior University highlight his role as a key innovator in the field. His work continues to influence the understanding of genetic variations and their implications for health and disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
